AR084169A1 - Combinacion que comprende un derivado de la familia de las combretastatinas y cetuximab - Google Patents
Combinacion que comprende un derivado de la familia de las combretastatinas y cetuximabInfo
- Publication number
- AR084169A1 AR084169A1 ARP110104553A ARP110104553A AR084169A1 AR 084169 A1 AR084169 A1 AR 084169A1 AR P110104553 A ARP110104553 A AR P110104553A AR P110104553 A ARP110104553 A AR P110104553A AR 084169 A1 AR084169 A1 AR 084169A1
- Authority
- AR
- Argentina
- Prior art keywords
- cetuximab
- combination
- combretastatinas
- family derivative
- family
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1060293A FR2968557A1 (fr) | 2010-12-09 | 2010-12-09 | Combinaison antitumorale comprenant un derive de la famille des combretastatines et le cetuximab |
Publications (1)
Publication Number | Publication Date |
---|---|
AR084169A1 true AR084169A1 (es) | 2013-04-24 |
Family
ID=43837735
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP110104553A AR084169A1 (es) | 2010-12-09 | 2011-12-06 | Combinacion que comprende un derivado de la familia de las combretastatinas y cetuximab |
Country Status (5)
Country | Link |
---|---|
AR (1) | AR084169A1 (fr) |
FR (1) | FR2968557A1 (fr) |
TW (1) | TW201306833A (fr) |
UY (1) | UY33789A (fr) |
WO (1) | WO2012076688A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2889530A1 (fr) * | 2012-10-25 | 2014-05-01 | Glaxosmithkline Llc | Combinaison |
US20170128592A1 (en) * | 2015-10-01 | 2017-05-11 | Indian Institute Of Technology, Bombay | Targeted polymeric nano-complexes as drug delivery system |
CN112225673B (zh) * | 2020-11-13 | 2022-08-02 | 义乌市华耀医药科技有限公司 | 氨基康普立停衍生物及其应用 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4996237A (en) | 1987-01-06 | 1991-02-26 | Arizona Board Of Regents | Combretastatin A-4 |
TW325458B (en) | 1993-09-08 | 1998-01-21 | Ajinomoto Kk | Stilbene derivatives and pharmaceutical compositions comprising the same for anti-cancer |
US5731353A (en) | 1993-09-08 | 1998-03-24 | Ajinomoto Co., Inc. | Stilbene derivatives and pharmaceutical compositions containing them |
TW334418B (en) | 1995-03-07 | 1998-06-21 | Ajinomoto Kk | Stilbene derivatives and pharmaceutical compositions |
CN1140272C (zh) | 1998-04-03 | 2004-03-03 | 味之素株式会社 | 抗肿瘤剂 |
US20020183266A1 (en) | 2001-03-15 | 2002-12-05 | Aventis Pharma, S.A. | Combination comprising combretastatin and anticancer agents |
ATE489080T1 (de) | 2001-06-25 | 2010-12-15 | Ajinomoto Kk | Antitumorale mittel |
FR2838437B1 (fr) | 2002-04-11 | 2004-06-04 | Aventis Pharma Sa | Procedes de preparation de combretastatines |
GB0410817D0 (en) * | 2004-05-14 | 2004-06-16 | Angiogene Pharm Ltd | Vascular damaging therapy |
FR2895258B1 (fr) | 2005-12-22 | 2008-03-21 | Aventis Pharma Sa | Combinaison comprenant de la combretastatine et des agents anticancereux |
RU2010128239A (ru) * | 2007-12-13 | 2012-01-20 | Новартис АГ (CH) | Комбинации терапевтических средств, предназначенных для лечения рака |
US20090209496A1 (en) * | 2008-02-15 | 2009-08-20 | David Chaplin | Methods and compositions for enhancing the efficacy of rtk inhibitors |
FR2945210B1 (fr) * | 2009-05-07 | 2011-07-01 | Sanofi Aventis | Combinaison antitumorale comprenant l'ave8062 et le sorafenib |
-
2010
- 2010-12-09 FR FR1060293A patent/FR2968557A1/fr active Pending
-
2011
- 2011-12-06 AR ARP110104553A patent/AR084169A1/es not_active Application Discontinuation
- 2011-12-09 UY UY0001033789A patent/UY33789A/es unknown
- 2011-12-09 TW TW100145626A patent/TW201306833A/zh unknown
- 2011-12-09 WO PCT/EP2011/072310 patent/WO2012076688A1/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
UY33789A (es) | 2012-07-31 |
TW201306833A (zh) | 2013-02-16 |
WO2012076688A1 (fr) | 2012-06-14 |
FR2968557A1 (fr) | 2012-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP13013074A (es) | Nuevos derivados de piridina | |
AR077629A1 (es) | Mimetico de smac | |
UY33183A (es) | Compuestos inhibidores de virus flaviviridae, composición farmaceutica que los contiene y su uso en la manufactura de un medicamento | |
CO6430459A2 (es) | Derivados de prolina como inhibidores de catepsina | |
GT201400012A (es) | Compuesto inhibidor de la señalizacion de la trayectoria notch | |
CU20140068A7 (es) | Triazolopiridinas sustituidas | |
AR090456A1 (es) | Combinaciones farmaceuticas que comprenden un analogo de tionucleotidos | |
SV2011004019A (es) | 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso | |
ECSP12012103A (es) | Inhibidores de virus flaviviridae. | |
CR20120596A (es) | 5-fluoro-1h-pirazolopiridinas sustituidas y su uso | |
CO6620055A2 (es) | Ciertas amino-pirimidinas, composiciones de las mismas y métodos para el uso de los mismos | |
CR20150250A (es) | Nuevos derivados de piridina | |
CU20140072A7 (es) | Derivados de dihidro-oxazina y dihidro-pirido-oxazina | |
CR20140134A (es) | Composiciones farmacéuticas | |
CR20150204A (es) | Nuevos derivados de piridina | |
CR20110219A (es) | Ácidos naftilacéticos | |
HN2011003403A (es) | Sulfonamidas heterociclicas, usos y composiciones farmaceuticas de las mismas | |
CO6390102A2 (es) | Combinacion anitumoral que comprende ave8062 y sorafenib | |
UY33794A (es) | Inhibidores diméricos de las iap | |
UY33236A (es) | Inhibidores dimericos de las iap | |
AR090806A1 (es) | Glucosidos de pirazol y su utilizacion en el tratamiento de la diabetes tipo i y ii | |
UY32404A (es) | 4-aril-butan-1,3-diamidas | |
AR082215A1 (es) | Composicion farmaceutica agradable al paladar | |
EA201490199A1 (ru) | Терапевтические способы | |
CU20140028A7 (es) | Compuesto de benzotiazolona |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |